Programming of implantable cardioverter defibrillators for primary prevention: outcomes at centers with high vs. low concordance with guidelines

Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation. 2018;138(13):e272–391. https://doi.org/10.1161/CIR.0000000000000549.

Article  PubMed  Google Scholar 

Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335(26):1933–40. https://doi.org/10.1056/NEJM199612263352601.

Article  CAS  PubMed  Google Scholar 

Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877–83. https://doi.org/10.1056/NEJMoa013474.

Article  PubMed  Google Scholar 

Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–37. https://doi.org/10.1056/NEJMoa043399.

Article  CAS  PubMed  Google Scholar 

Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140–50. https://doi.org/10.1056/NEJMoa032423.

Article  CAS  PubMed  Google Scholar 

Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. EP Europace. 2015;18(2):159–83. https://doi.org/10.1093/europace/euv411.

Article  Google Scholar 

Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51(14):1357–65. https://doi.org/10.1016/j.jacc.2007.09.073.

Article  PubMed  Google Scholar 

Iftikhar S, Mattu A, Brady W. ED evaluation and management of implantable cardiac defibrillator electrical shocks. Am J Emerg Med. 2016;34(6):1140–7. https://doi.org/10.1016/j.ajem.2016.02.060.

Article  PubMed  Google Scholar 

Ruwald AC, Schuger C, Moss AJ, Kutyifa V, Olshansky B, Greenberg H, et al. Mortality reduction in relation to implantable cardioverter defibrillator programming in the multicenter automatic defibrillator implantation trial-reduce inappropriate therapy (MADIT-RIT). Circulation: Arrhythmia and Electrophysiol. 2014;7(5):785–92. https://doi.org/10.1161/CIRCULATIONAHA.113.004196.

Article  Google Scholar 

Gasparini M, Proclemer A, Klersy C, Kloppe A, Lunati M, Ferrer JBM, et al. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA. 2013;309(18):1903–11. https://doi.org/10.1001/jama.2013.4598.

Article  CAS  PubMed  Google Scholar 

Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367(24):2275–83. https://doi.org/10.1056/NEJMoa1211107.

Article  CAS  PubMed  Google Scholar 

Saeed M, NEASON CG, RAZAVI M, CHANDIRAMANI S, ALONSO J, NATARAJAN MS, et al. Programming Antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial. J Cardiovasc Electrophysiol. 2010;21(12):1349–54. https://doi.org/10.1111/j.1540-8167.2010.01825.x.

Article  PubMed  Google Scholar 

Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (primary prevention parameters evaluation) study. J Am Coll Cardiol. 2008;52(7):541–50. https://doi.org/10.1016/j.jacc.2008.05.011.

Article  PubMed  Google Scholar 

Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A, et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [role of long detection window programming in patients with left ventricular dysfunction, non-ischemic etiology in primary prevention treated with a biventricular ICD] study. Eur Heart J. 2009;30(22):2758–67. https://doi.org/10.1093/eurheartj/ehp247.

Article  PubMed  PubMed Central  Google Scholar 

Aktas MK, Bennett AL, Younis A, Kutyifa V, Polonsky B, McNitt S, et al. Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the multicenter automatic defibrillator implantation trial-reduce inappropriate therapy (MADIT-RIT). Heart Rhythm 02. 2020;1(2):77–82. https://doi.org/10.1016/j.hroo.2020.04.001.

Article  Google Scholar 

Tan VH, Wilton SB, Kuriachan V, Sumner GL, Exner DV. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality. Circ: Arrhythmia Electrophysiol. 2014;7(1):164–70. https://doi.org/10.1161/CIRCEP.113.001217.

Article  Google Scholar 

Stiles MK, Fauchier L, Morillo CA, Wilkoff BL. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Heart Rhythm. 2020;17(1):e220–8. https://doi.org/10.1016/j.hrthm.2019.02.034.

Article  PubMed  Google Scholar 

Ananwattanasuk T, Tanawuttiwat T, Chokesuwattanaskul R, Lathkar-Pradhan S, Barham W, Oral H, et al. Programming implantable cardioverter–defibrillator in primary prevention: guideline concordance and outcomes. Heart Rhythm. 2020;17(7):1101–6. https://doi.org/10.1016/j.hrthm.2020.02.004.

Article  PubMed  Google Scholar 

Sun S, Johnson J, Degroot P, Brown ML, Obel O. Effect of ICD therapies on mortality in the OMNI trial. J Cardiovasc Electrophysiol. 2016;27(2):192–9. https://doi.org/10.1111/jce.12860.

Article  PubMed  Google Scholar 

Thøgersen AM, Larsen JM, Johansen JB, Abedin M, Swerdlow CD. Failure to treat life-threatening ventricular tachyarrhythmias in contemporary implantable cardioverter-defibrillators: implications for strategic programming. Circ Arrhythm Electrophysiol. 2017;10(9):e005305. https://doi.org/10.1161/CIRCEP.117.005305.

Article  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif